As warned by experts, the promise of a COVID-19 vaccine by election day were exaggerated. The world has entered into a critical period for the coronavirus wherin we once anticipated the fabled Thanksgiving...
Simply put: If a vaccine is available, who will take it? Pfizer alone estimates 100 million doses of their vaccine will be available. That figure is roughly between 1/4 to 1/3 the population of the United States. In recent polls, only 25% of Americans...
Pfizer and BioNTech biopharmaceutics announced today a $1.95 billion dollar agreement with the U.S. government for 100 million doses of the partnership's BNT162 program vaccine.
As manufacturers worldwide race to develop the first viable COVID-19 vaccine faster than any vaccine ever developed in human history, late November remains an important date in the United States to vaccinate a large number of Americans.